Table 1 Demographic and clinical characteristics of CKD patients seen in control and intervention clinics during the study period
Variable | Control clinic | Intervention clinic | P value |
|---|---|---|---|
(n = 418) | (n = 363) | ||
Age (years) | 71.0 (10.3) | 71.0 (10.7) | 0.99 |
Gender (% male (N)) | 95.9% (401) | 94.5% (343) | 0.34 |
Race (% black (N)) | 45.9% (192) | 44.9% (163) | 0.77 |
Past Medical History (% (N)) | |||
Diabetes | 50.2% (210) | 44.9% (163) | 0.14 |
Hypertension | 93.1% (389) | 97.0% (352) | 0.013 |
Coronary artery disease | 31.6% (132) | 40.8% (148) | 0.008 |
Cancer | 21.1% (88) | 21.8% (79) | 0.81 |
Last systolic BP (mmHg) | 133.1 (18.4) | 132.4 (17.9) | 0.63 |
Last diastolic BP (mmHg) | 72.8 (11.7) | 71.6 (12.2) | 0.17 |
Renal function | |||
Average eGFR during study period* | 47.8 (40, 56) | 48.1 (39, 55) | 0.40 |
Stage of CKD (%) | |||
III | 91.6% | 89.5% | 0.52 |
IV | 7.7% | 9.9% | |
V | 0.7% | 0.6% | |
Proteinuria | 24.2% | 20.7% | 0.24 |
Most recent laboratory results | |||
PTH* | 104 (61, 184) | 95 (62, 156) | 0.74 |
Phosphorus | 3.7 (0.7) | 3.7 (0.7) | 0.54 |
Hemoglobin | 12.8 (1.9) | 12.6 (1.8) | 0.35 |
Number of clinic visits during study period | 2.4 (1.4) | 2.3 (1.4) | 0.30 |
Seen by nephrology during the study period | 16.3% | 19.8% | 0.19 |
Seen in urgent care during the study period | 49.8% | 52.9% | 0.38 |